ArticlemedRxiv : the preprint server for health sciences2023

Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.

Angela R Branche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.